Niknejad Hassan, Mahmoudzadeh Raziyeh
Department of Tissue Engineering, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res. 2015 Spring;14(2):385-94.
In the last step of desolvation method for preparation of albumin nanoparticles, glutaraldehyde (GA) is added to stabilize the newly formed nanoparticles. Due to undesirable effects of GA, the objective of this study was to evaluate alternative methods of crosslinking including ultraviolet (UV) irradiation, adding of glucose and combination of both methods. The nanoparticles were prepared by desolvation procedure. Final particle size, zeta potential, FTIR, scanning electron micrograph, cellular uptake and cell toxicity of nanoparticles crosslinked with UV and/or glucose were compared with commonly crosslinked nanoparticles with GA. Moreover, drug release and stability parameters of docetaxel-loaded albumin nanoparticles were investigated. Size of all nanoparticles prepared by different methods was in the same range (100-200 nm). Zeta potential showed the same results except for those treated with UV. The results of FTIR assay were the same for all groups. Although crosslinking by UV or glucose alone resulted in cytotoxic effects, combination of UV and glucose had less cytotoxic effects compared to GA. Cellular uptake of nanoparticles crosslinked with UV + glucose and GA showed similar results. The release of docetaxel from UV + glucose and GA crosslinked nanoparticles showed the same biphasic release. These data support the idea that crosslinking with a combination of UV and glucose can be a promising alternative method for production of docetaxel-loaded albumin nanoparticles with the advantage of omitting toxic GA.
在用于制备白蛋白纳米颗粒的去溶剂化方法的最后一步中,添加戊二醛(GA)以稳定新形成的纳米颗粒。由于GA存在不良影响,本研究的目的是评估包括紫外线(UV)照射、添加葡萄糖以及两种方法联合使用在内的交联替代方法。纳米颗粒通过去溶剂化程序制备。将经紫外线和/或葡萄糖交联的纳米颗粒的最终粒径、zeta电位、傅里叶变换红外光谱(FTIR)、扫描电子显微镜图像、细胞摄取和细胞毒性与常用GA交联的纳米颗粒进行比较。此外,还研究了载多西他赛白蛋白纳米颗粒的药物释放和稳定性参数。通过不同方法制备的所有纳米颗粒的尺寸都在相同范围内(100 - 200纳米)。除了经紫外线处理的纳米颗粒外,zeta电位显示出相同的结果。所有组的FTIR分析结果相同。尽管单独用紫外线或葡萄糖交联会产生细胞毒性作用,但与GA相比,紫外线和葡萄糖联合使用产生的细胞毒性作用较小。经紫外线 + 葡萄糖和GA交联的纳米颗粒的细胞摄取显示出相似的结果。多西他赛从经紫外线 + 葡萄糖和GA交联的纳米颗粒中的释放显示出相同的双相释放。这些数据支持这样一种观点,即紫外线和葡萄糖联合交联可以成为一种有前景的替代方法,用于生产载多西他赛的白蛋白纳米颗粒,其优点是无需使用有毒的GA。